World's Best Scientists 2026 revealed!
Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Immunology

D-Index
89
Citations
28170
World Ranking
1116
National Ranking
11

Medicine

D-Index
89
Citations
28182
World Ranking
12722
National Ranking
148

Pierre Coulie publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pierre Coulie sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 332 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pierre Coulie D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Coulie sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award

Overview

Pierre Coulie is affiliated with the Université Catholique de Louvain in Belgium. Their research primarily lies within the field of Medicine, with significant contributions to Oncology, Immunology, Rheumatology, Molecular Biology, and Cancer Research.

Their recent publications cover a range of topics related to cancer immunotherapy, immune responses, and autoimmune diseases. Notable papers include:

  • Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer, 2020, Nature Communications
  • An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial, 2020, OncoImmunology
  • Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue, 2021, Frontiers in Immunology
  • Paired Rheumatoid Arthritis Synovial Biopsies From Small and Large Joints Show Similar Global Transcriptomic Patterns With Enrichment of Private Specificity TCRB and TCR Signaling Pathways, 2020, Frontiers in Immunology
  • Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis, 2022, Blood

The scientist frequently collaborates with several co-authors including Nicolas van Baren, Sophie Lucas, Christine Galant, Grégoire de Streel, and Nisha Limaye.

Their work has been published in multiple venues such as:

  • Frontiers in Immunology
  • Cancer Research
  • Nature Communications
  • OncoImmunology
  • Blood

Main research topics explored by Pierre Coulie are:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Vaccines and immunoinformatics approaches
  • Lymphoma Diagnosis and Treatment

Best Publications

  • Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

    Pierre G. Coulie;Benoît J. Van den Eynde;Pierre van der Bruggen;Thierry Boon

  • The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

    V Brichard;A Van Pel;T Wölfel;C Wölfel

  • A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

    P G Coulie;V Brichard;A Van Pel;T Wölfel

  • Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

    M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard

  • Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

    Hideyuki Ikeda;Bernard Lethé;Frédéric Lehmann;Nicolas Van Baren

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • HUMAN T CELL RESPONSES AGAINST MELANOMA

    Thierry Boon;Pierre G Coulie;Benoît J Van den Eynde;Pierre van der Bruggen

  • Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

    J Van Snick;S Cayphas;A Vink;C Uyttenhove

  • Bage - a New Gene Encoding An Antigen Recognized On Human Melanomas By Cytolytic T-lymphocytes

    Pascale Boël;Claude Wildmann;Maria Luisa Sensi;Robert Brasseur

  • Tumor antigens recognized by T cells

    Thierry Boon;Pierre G. Coulie;Benoît Van den Eynde

  • A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

    Pierre G. Coulie;Frederic Lehmann;Bernard Lethe;Jean Herman

  • The determinants of tumour immunogenicity.

    Thomas Blankenstein;Thomas Blankenstein;Pierre G. Coulie;Eli Gilboa;Elizabeth M. Jaffee

  • A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

    P van der Bruggen;J Bastin;T Gajewski;T Gajewski;P G Coulie

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

    Jurjen Tel;Erik H.J.G. Aarntzen;Tetsuro Baba;Gerty Schreibelt

  • T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.

    C Uyttenhove;P G Coulie;J Van Snick

  • Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg.

    Julie Stockis;Didier Colau;Pierre G. Coulie;Sophie Lucas

  • A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia

    H. Dolstra;H. Fredrix;F.M.H.M. Maas;P.G. Coulie

  • Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape

    Abhishek D. Garg;Pierre G. Coulie;Benoit J. Van den Eynde;Patrizia Agostinis

  • Genes coding for tumor-antigens recognized by cytolytic T-lymphocytes

    Aline Van Pel;Pierre Van Der Bruggen;Pierre G. Coulie;Vincent G. Brichard

  • Purification and NH2-terminal Amino-acid-sequence of a New T-cell Derived Lymphokine With Growth-factor Activity for B-cell Hybridomas

    Jacques Van Snick;S. Cayphas;A. Vink;Catherine Uyttenhove

Frequent Co-Authors

Thierry Boon
Thierry Boon Ludwig Cancer Research
Pierre van der Bruggen
Pierre van der Bruggen Université Catholique de Louvain
Jean-Christophe Renauld
Jean-Christophe Renauld Université Catholique de Louvain
Francis Brasseur
Francis Brasseur Ludwig Cancer Research
Benoît Van den Eynde
Benoît Van den Eynde Ludwig Cancer Research
Thomas F. Gajewski
Thomas F. Gajewski University of Chicago
Laure Dumoutier
Laure Dumoutier Université Catholique de Louvain
Catia Traversari
Catia Traversari MolMed (Italy)
Jacques Van Snick
Jacques Van Snick Université Catholique de Louvain
J Van Snick
J Van Snick Université Catholique de Louvain

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related fields such as nursing can open up diverse career opportunities. Many professionals choose online programs like the easiest online nurse practitioner programs to advance their qualifications while balancing work and study.

Specifically, the psychiatric mental health nurse practitioner (PMHNP) pathway is popular among those drawn to healthcare's immunological and neurological aspects. Programs with strong clinical components are essential, and students often seek options with high-quality placements. You can find some of the top psychiatric mental health nurse practitioner programs online that emphasize hands-on experience.

Cost is another critical factor. Many prospective students explore the cheapest pmhnp certificate programs to minimize debt while accessing quality education tailored to their needs.

After completing advanced degrees like the DNP, career outlooks are promising. Salaries vary by location and specialization, making it helpful to research specifics. To gauge earning potential, refer to the dnp salary data by state.

Best Scientists Citing Pierre Coulie

Trending Scientists

Recently Published Articles